Lexaria Bioscience (NASDAQ:LEXX) is a pharmaceutical and biotechnology company focused on developing and commercializing its proprietary DehydraTECH platform, a lipid-based delivery technology designed to enhance the oral absorption of active molecules. The company’s core technology facilitates faster onset of action, increased bioavailability and more consistent dosing for a variety of compounds, including cannabinoids, nicotine, nonsteroidal anti-inflammatory drugs (NSAIDs) and certain prescription pharmaceuticals.
Through DehydraTECH, Lexaria has advanced multiple consumer health and pharmaceutical programs. On the consumer side, the company has launched or licensed formulations such as nicotine pouches and cannabidiol (CBD)-infused food and beverage products. In the pharmaceutical arena, Lexaria is collaborating with partners to explore enhanced delivery of antiviral agents and cardiovascular drugs, leveraging its platform to support repurposed or new chemical entities that may benefit from improved oral uptake.
Founded in 2015 and headquartered in Kelowna, British Columbia, Lexaria operates research laboratories in both Canada and the United States. Its global patent portfolio spans more than 20 families of intellectual property, covering applications in North America, Europe, Asia and other key markets. The company supports ongoing clinical and preclinical studies, while pursuing licensing and co-development agreements to extend its platform’s reach across multiple therapeutic areas and geographies.
Under the leadership of founder and Chief Executive Officer Dr. Chris Bunka, Lexaria’s management team combines expertise in drug development, regulatory affairs and consumer product commercialization. Chief Scientific Officer Dr. David Mowry directs R&D efforts, and the board includes industry veterans with backgrounds in pharmaceuticals, life-science investment and manufacturing. Together, they aim to position DehydraTECH as a versatile solution for improving the delivery and performance of active pharmaceutical and nutraceutical ingredients.
